Skip to main content
Clinical Trials/DRKS00018776
DRKS00018776CompletedPhase 2

Efficacy of acupuncture treatments on frequency and intensity of pain attacks in patients with idiopathic or classic trigeminal neuralgia - ACUTRIG ACUpuncture in TRIGeminal neuralgia

Charité Campus Charité Mitte0 sites20 target enrollmentStarted: September 6, 2019Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to 85 Years (—)
Sex
All

Inclusion Criteria

  • 1.Confirmed diagnosis of idiopathic or classical trigeminal neuralgia
  • 2.Age between 18- 85yrs
  • 3.At least 3 attacks per day, with an intensity of at least 4 on a NRS, on at least 4 days per week
  • 4.Stable (unchanged dose since 4 weeks) prophylactic medication (e.g.: carbamazepine, oxcarbazepine, baclofen, phenytoin, gabapentin, lamotrigine etc.)
  • 5.Stable concomitant medication with possible influence on trigeminal neuralgia (antidepressants, duloxetine)
  • 6.Patient is ready to take part in randomization process, and willing to fill out diaries
  • 7.Patient provided written and oral consent to participation in study

Exclusion Criteria

  • 1.Symptomatic or secondary trigeminal neuralgia (due to Multiple Sclerosis, tumors etc.) or additional SUNCT, SUNA or paroxysmal hemicranias or cluster headaches
  • 2.Use of opioids or opiates before inclusion into study
  • 3.Frequent or chronic THC or Cannabis use before inclusion into study or during study
  • 4.Psychotherapy during three months before study or planned during study participation
  • 5.Additional complementary or alternative treatment 4 weeks before inclusion into study or during study participation
  • new 5a: acupuncture in the 12 weeks before study onset.
  • 6.For female patients pregnancy or breast- feeding
  • 7.Somatic or mental illness that prevent from participation in the study (e.g. bleeding disorders, oral anticoagulation, psychosis)
  • 8.Alcohol or drug abuse
  • 9.Missing knowledge of German language
  • 10.Participation in other interventional studies
  • 11.Ongoing incapacity pension process
  • 12.Planned rehabilitation during study participation

Investigators

Sponsor
Charité Campus Charité Mitte

Similar Trials